arXiv:2607. 05825v1 Announce Type: cross Abstract: Background.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv AI.
The study presents an interpretable AI framework for glaucoma screening using low-cost handheld retinal cameras in a West African population. Trained on 681 participants, the system achieved high performance across vessel segmentation, cup/disc segmentation, and optic nerve head feature detection, with classification AUCs of 0.85 for the handheld device and 0.93 for a tabletop camera. The model provides confidence scores and visual explanations to aid clinical interpretation.
The paper presents an explainable diabetic retinopathy classification framework that leverages vision foundation models—DINOv2, CLIP, and Vision Transformer—combined with various transfer learning techniques such as full fine‑tuning, linear probing, and Low‑Rank Adaptation (LoRA). Using the ODIR dataset for internal validation and the APTOS dataset for external testing, DINOv2‑LoRA achieved the best internal AUROC (0.758) while DINOv2 and ViT full fine‑tuning reached the highest external AUROC (0.920). Explainability was assessed with Grad‑CAM and HiResCAM against expert‑annotated lesion masks from IDRiD, using Dice, IoU, and Pointing Game metrics, confirming that model attention aligns with clinically relevant retinal lesions.
arXiv:2607. 21068v1 Announce Type: new Abstract: Automated detection of vision impairing retina-based ocular conditions from fundus images is important for early screening, timely referral and reducing dependency on specialist-only assessment, for which neural network-based deep learning (DL) models have been widely utilized.
arXiv:2607. 19864v1 Announce Type: cross Abstract: Diabetic retinopathy is a leading cause of preventable blindness; its early lesions are small, low contrast, and easily missed in manual screening.
The paper presents a two‑pipeline framework for retinal fundus analysis that combines four‑class disease classification with vessel segmentation. It fine‑tunes eight ImageNet‑pretrained CNNs on the FIVES dataset, applies five gradient‑based explanation methods to assess model interpretability, and benchmarks ten U‑Net variants—including transformer‑based and attention‑enhanced architectures—on the FIVES and DRIVE datasets. The best classification results come from ResNet101 (94.17% accuracy), while the strongest segmentation performance is achieved by Attention U‑Net with a ResNet101V2 backbone, improving DRIVE IoU from 60.80% to 64.83%.
The paper introduces GlobeReady, a clinician-friendly platform that leverages the RetiGlobe foundation model for ophthalmic image diagnostics without requiring fine-tuning. RetiGlobe was pretrained in two stages: first with self-supervised learning on 38 million synthetic images, then with contrastive learning on 475,845 real image‑text pairs from diverse ethnicities, devices, and regions. GlobeReady was evaluated on 488,448 images from multiple international centers and tested prospectively with 31 ophthalmologists, also exploring domain generalisability, uncertainty quantification, OOD detection, and feature-based case retrieval.